CEO Abizer Gaslightwala discusses Akari’s novel PH1 payload strategy and execution priorities supporting AKTX-101’s ...
I'm Tondemina, a fresh graduate and pure Japanese who reincarnated into a different world as a strategy consultant in Canada.
Zacks Investment Research on MSN
ISRG Q3 earnings call highlights pricing and growth strategy
Intuitive Surgical, Inc. ISRG used its third-quarter 2026 earnings call to outline instrument pricing reductions aimed at ...
I will start with the conclusion. If the products are almost the same, whether you are chosen or not is determined by ...
Custom Health will close the market at the Toronto Stock Exchange on October 22, 2026, to celebrate the Company's recent ...
MannKind Corporation recently presented new clinical data at the 2026 Heart Failure Society of America meeting showing that ...
MarTech on MSN
Your brand isn’t as differentiated as you think
The tools meant to make marketing more effective may be making brands more alike. Here's why differentiation is becoming ...
Deep inside every skeletal muscle, scattered among the fibers that generate force, lives a population of stromal cells with a ...
Consumer financial services company Synchrony Financial (NYSE: SYF) met Wall Street’s revenue expectations in Q3 2026, but ...
Akari's CEO outlines plans for AKTX-101 and the importance of novel ADC payloads in cancer treatment advancements.
Sincerely, L. Kevin Kelly Chairman and Chief Executive Officer Cycurion, Inc.
A review of preclinical evidence finds that nanomaterials can improve mitochondrial targeting, organelle protection and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results